A Single Nucleotide Exchange in the wzy Gene Is Responsible for the Semirough O6 Lipopolysaccharide Phenotype and Serum Sensitivity of Escherichia coli Strain Nissle 1917

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Bacteriology

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JB.184.21.5912-5925.2002PMID 12374825PMCID PMC135379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endotoxin in Health and Disease

  2020cited by this paper
• The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties

  2005cited by this paper
• The O-Antigen Gene Cluster of Escherichia coli O55:H7 and Identification of a New UDP-GlcNAc C4 Epimerase Gene

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Ecological fitness, genomic islands and bacterial pathogenicity

  2001cited by this paper
• Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP).

  2000cited by this paper
• The Staden package, 1998.

  2000cited by this paper
• Distribution of Core Oligosaccharide Types in Lipopolysaccharides from Escherichia coli

  2000cited by this paper
• The structures of the carbohydrate backbones of the lipopolysaccharides from Escherichia coli rough mutants F470 (R1 core type) and F576 (R2 core type).

  1999cited by this paper
• Carbohydrates and their derivatives including tannins, cellulose, and related lignins

  1999cited by this paper
• Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

  1999cited by this paper
• 3.09 – Lipopolysaccharides

  1999cited by this paper
• Molecular Characterization of the Locus Encoding Biosynthesis of the Lipopolysaccharide O Antigen of Escherichia coliSerotype O113

  1999cited by this paper
• Genetic organization of the O7-specific lipopolysaccharide biosynthesis cluster of Escherichia coli VW187 (O7:K1).

  1999cited by this paper
• Nutritional uniqueness of cats.

  1998cited by this paper
• Sequencing of Escherichia coli O111 O-Antigen Gene Cluster and Identification of O111-Specific Genes

  1998cited by this paper
• Organization of Escherichia coli O157 O Antigen Gene Cluster and Identification of Its Specific Genes

  1998cited by this paper
• Comparison of Loss of Serum Resistance by Defined Lipopolysaccharide Mutants and an Acapsular Mutant of UropathogenicEscherichia coli O75:K5

  1998cited by this paper
• Linkage Map of Escherichia coli K-12, Edition 10: The Traditional Map

  1998cited by this paper
• Probiotics and E. coli infections in man.

  1998cited by this paper
• Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica

  1998cited by this paper
• Linkage Map of Escherichia coli K-12, Edition 10: The Traditional Map

  1998cited by this paper
• Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

  1997cited by this paper
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

  1997cited by this paper
• Escherichia coli: mechanisms of virulence.

  1997cited by this paper
• Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

  1997cited by this paper
• Detection of lipid A by monoclonal antibodies in S-form lipopolysaccharide after acidic treatment of immobilized LPS on Western blot

  1997cited by this paper
• Structural and serological characterisation of two O-specific polysaccharides of Acinetobacter.

  1996cited by this paper
• Efficient random subcloning of DNA sheared in a recirculating point-sink flow system.

  1996cited by this paper
• Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 by insertional mutagenesis using a nonpolar chloramphenicol resistance cassette

  1996cited by this paper
• Properties ofEscherichia coli strains of serotype O6

  1995cited by this paper
• Role of O-antigen variation in the immune response.

  1995cited by this paper
• Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients.

  1994cited by this paper
• Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides.

  1994cited by this paper
• [Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)].

  1994cited by this paper
• Structural comparison of the O6 specific polysaccharides from E. coli O6:K2:H1, E. coli O6:K13:H1, and E. coli O6:K54:H10.

  1994cited by this paper
• New cloning vectors for integration into the λ attachment site attB of the Escherichia coli chromosome

  1992cited by this paper
• Pathogenicity and molecular genetics of O-specific side-chain lipopolysaccharides of Escherichia coli.

  1992cited by this paper
• Bacterial Endotoxic Lipopolysaccharides

  1992cited by this paper
• New cloning vectors for integration in the lambda attachment site attB of the Escherichia coli chromosome.

  1992cited by this paper
• Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum.

  1992cited by this paper
• Escherichia coli serotyping and disease in man and animals.

  1992cited by this paper
• Structural Aspects of LPS: Role in Evasion of Host Defense Mechanism

  1991cited by this paper
• Microbial Surface Components and Toxins in Relation to Pathogenesis

  1991cited by this paper
• Analysis of lipopolysaccharide (lipid A) fatty acids

  1990cited by this paper
• Bacterial virulence versus host resistance in the urinary tracts of mice

  1987cited by this paper
• Escherichia Coli and Salmonella: Typhimurium Cellular and Molecular Biology

  1987cited by this paper
• Linkage Map of Escherichia coli K-12

  1987cited by this paper
• Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen

  1984cited by this paper
• Structural studies of the Escherichia coli O-antigen 6.

  1983cited by this paper
• Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants

  1982cited by this paper
• Precise location of two promoters for the beta-lactamase gene of pBR322. S1 mapping of ribonucleic acid isolated from Escherichia coli or synthesized in vitro.

  1982cited by this paper
• A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

  1982cited by this paper
• Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli

  1982cited by this paper
• Adhesion of commensal bacteria to the large intestine wall in humans

  1979cited by this paper
• Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

  1977cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• A new method for the extraction of R lipopolysaccharides.

  1969cited by this paper
• Quantitative Determination of Monosaccharides as Their Alditol Acetates by Gas Liquid Chromatography.

  1965cited by this paper
• Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure

  1965influential reference
• A sensitive colorimetric method for the estimation of 2-deoxy sugars with the use of the malonaldehyde-thiobarbituric acid reaction.

  1959cited by this paper
• Composition of the cell wall of Staphylococcus aureus: its relation to the mechanism of action of penicillin.

  1959cited by this paper
• The quantitative histochemistry of brain. II. Enzyme measurements.

  1954cited by this paper
• The quantitative histochemistry of brain. I. Chemical methods.

  1954cited by this paper
• THE QUANTITATIVE HISTOCHEMISTRY OF THE BRAIN

  1953cited by this paper

• Whole-cell catalysis of N-acetylglucosamine into N-acetylneuraminic acid using a dual-pathway conversion in engineered Escherichia coli Nissle 1917.

  2026cites this paper
• GPC3 and CD133-targeted peptide dual modification enhances the therapeutic effect of doxorubicin carried by OMVs on hepatocellular carcinoma.

  2026cites this paper
• Bioengineered probiotics derived bacterial extracellular vesicle as bioactive nanocarrier for the local VEGF expression to accelerate wound healing.

  2026cites this paper
• A microbiota-derived bile acid modulates biofilm formation by the probiotic strain Escherichia coli Nissle 1917

  2025cites this paper
• Role for RTX-family toxin HlyA of extraintestinal pathogenic Escherichia coli in serum resistance

  2025cites this paper
• Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson's disease.

  2025cites this paper
• Construction of probiotic Escherichia coli Nissle 1917 as a next-generation expression platform and its application in therapeutic protein production

  2025cites this paper
• Not quite a cure yet: unlocking the unfulfilled promise of live biotherapeutics for disease treatment

  2025cites this paper
• Synergy between Group 2 capsules and lipopolysaccharide underpins serum resistance in extra-intestinal pathogenic Escherichia coli

  2024cites this paper
• Top-Down Characterization of Bacterial Lipopolysaccharides and Lipooligosaccharides Using Activated-Electron Photodetachment Mass Spectrometry.

  2024cites this paper
• Engineered probiotic E.coli Nissle 1917 for release PTEN to improve the tumor microenvironment and suppress tumor growth

  2024cites this paper
• At what cost? The impact of bacteriophage resistance on the growth kinetics and protein synthesis of Escherichia coli

  2024cites this paper
• Comparative analysis of Escherichia coli Nissle 1917 ghosts quality: a study of two chemical methods

  2024cites this paper
• Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917

  2024cites this paper
• Efficient Cytotoxicity of Recombinant Azurin in Escherichia coli Nissle 1917-Derived Minicells against Colon Cancer Cells

  2023cites this paper
• Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden.

  2023cites this paper
• Diet, commensal microbiota‐derived extracellular vesicles, and host immunity

  2023cites this paper
• Construction of an autolytic system in Escherichia coli Nissle 1917 for efficient release of intracellular recombinant proteins

  2023cites this paper
• Safety considerations in the use of nonviable microbial cells as health-promoting agents in food and dietary supplements

  2023cites this paper
• Commensal Bacteria Impact on Intestinal Toll-like Receptor Signaling in Salmonella-Challenged Gnotobiotic Piglets

  2023cites this paper
• Effects of Escherichia coli Nissle 1917 on the Porcine Gut Microbiota, Intestinal Epithelium and Immune System in Early Life

  2022cites this paper
• A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles

  2022cites this paper
• Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment

  2022cites this paper
• Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917

  2022cites this paper
• Serial passage in an insect host indicates genetic stability of the human probiotic Escherichia coli Nissle 1917

  2022cites this paper
• Escherichia coli probiotic exhibits in vitro growth-limiting effects on clinical feline uropathogenic E coli isolates.

  2022cites this paper
• [Escherichia coli expressing gas vesicles is safe for enhancing the ablation effect of highintensity focused ultrasound in tumor-bearing mice].

  2021cites this paper
• Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic Escherichia coli Strain Nissle 1917

  2021cites this paper
• Surviving Serum: the Escherichia coli iss Gene of Extraintestinal Pathogenic E. coli Is Required for the Synthesis of Group 4 Capsule

  2021cites this paper
• Potential of Escherichia coli Probiotics for Improved Health and Disease Management

  2021cites this paper
• Prevalence of Escherichia coli in milk and some dairy products in Beni-Suef governorate, Egypt.

  2021cites this paper
• Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota

  2021cites this paper
• Serial passage of the human probiotic E. coli Nissle 1917 in an insect host leads to changed bacterial phenotypes

  2021cites this paper
• Evaluation of E. coli Nissle1917 derived metabolites in modulating key mediator genes of the TLR signaling pathway

  2021cites this paper
• Hypoxic Tumor Radiosensitization Using Engineered Probiotics

  2021cites this paper
• Glycine significantly enhances bacterial membrane vesicle production: a powerful approach for isolation of LPS‐reduced membrane vesicles of probiotic Escherichia coli

  2020influential citation
• Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

  2020cites this paper
• Characterization of the Riemerella anatipestifer M949_RS00050 gene.

  2020cites this paper
• Promising discovery of beneficial Escherichia coli in the human gut

  2020cites this paper
• Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages

  2020cites this paper
• Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition

  2020cites this paper
• Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3

  2020cites this paper
• Structural characterization of phosphoethanolamine-modified lipid A from probiotic Escherichia coli strain Nissle 1917

  2019cites this paper
• In Silico Serotyping Based on Whole-Genome Sequencing Improves the Accuracy of Shigella Identification

  2019cites this paper
• K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic E. coli Strain Nissle 1917

  2019cites this paper
• Substantial Extracellular Metabolic Differences Found Between Phylogenetically Closely Related Probiotic and Pathogenic Strains of Escherichia coli

  2019cites this paper
• High Mobility Group Box 1 and TLR4 Signaling Pathway in Gnotobiotic Piglets Colonized/Infected with L. amylovorus, L. mucosae, E. coli Nissle 1917 and S. Typhimurium

  2019cites this paper
• Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy

  2019cites this paper
• Advances in functional studies of probiotic Escherichia coli Nissle1917

  2019cites this paper
• Colonization of Germ-Free Piglets with Commensal Lactobacillus amylovorus, Lactobacillus mucosae, and Probiotic E. coli Nissle 1917 and Their Interference with Salmonella Typhimurium

  2019cites this paper
• Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease

  2019cites this paper
• The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation

  2018cites this paper
• Molecular serogrouping of Escherichia coli

  2018cites this paper
• E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy

  2018cites this paper
• Étude des métabolites liés à l’îlot pks chez les souches urinaires de Escherichia coli

  2018cites this paper
• Modulation of intestinal immune response by Outer Membrane Vesicles from probiotic and commensal Escherichia coli strains

  2018cites this paper
• Identification of a contact‐dependent growth inhibition system in the probiotic Escherichia coli Nissle 1917

  2018cites this paper
• Establishing a Multivariate Model for Predictable Antisense RNA-Mediated Repression.

  2018cites this paper
• E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro

  2018cites this paper
• Effects of Christensenella minuta lipopolysaccharide on RAW 264.7 macrophages activation.

  2018cites this paper
• E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization

  2018cites this paper
• Extraintestinal Pathogenic Escherichia coli.

  2018cites this paper
• Modulación de la barrera epitelial intestinal por vesículas de membrana y factores solubles secretados por cepas probióticas y comensales de Escherichia coli

  2017cites this paper
• Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products

  2017cites this paper
• Sequencing a piece of history :

  2017cites this paper
• Sequencing a piece of history: complete genome sequence of the original Escherichia coli strain

  2017cites this paper
• Draft genome sequence of Pseudomonas extremaustralis strain USBA-GBX 515 isolated from Superparamo soil samples in Colombian Andes

  2017cites this paper
• Escherichia coli Nissle 1917

  2017cites this paper
• Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

  2016cites this paper
• Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis

  2016cites this paper
• Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections

  2016cites this paper
• Characterization and cross-protection evaluation of M949_1603 gene deletion Riemerella anatipestifer mutant RA-M1

  2015cites this paper
• Lipopolysaccharide membrane building and simulation.

  2015cites this paper
• The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917

  2015cites this paper
• Escherichia coli EDL933 Requires Gluconeogenic Nutrients To Successfully Colonize the Intestines of Streptomycin-Treated Mice Precolonized with E. coli Nissle 1917

  2015cites this paper
• Inflammatory bowel disease associated with virulence factors in Escherichia coli

  2015cites this paper
• Disruption of Escherichia coli Nissle 1917 K5 Capsule Biosynthesis, through Loss of Distinct kfi genes, Modulates Interaction with Intestinal Epithelial Cells and Impact on Cell Health

  2015cites this paper
• The AS87_04050 Gene Is Involved in Bacterial Lipopolysaccharide Biosynthesis and Pathogenicity of Riemerella anatipestifer

  2014cites this paper
• Fur Is the Master Regulator of the Extraintestinal Pathogenic Escherichia coli Response to Serum

  2014cites this paper
• Bacterial self-defence: how Escherichia coli evades serum killing.

  2014influential citation
• Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats

  2014cites this paper
• The role of bacterial virulence factors in the clinical course of urinary tract infections

  2014cites this paper
• E. coli outer membrane and interactions with OmpLA.

  2014cites this paper
• Investigation of host-microbe interactions in the probiotic bacteria Escherichia coli Nissle 1917

  2014cites this paper
• Effects of orally administered Escherichia coli Nissle 1917 on growth performance and jejunal mucosal membrane integrity, morphology, immune parameters and antioxidant capacity in early weaned piglets

  2014cites this paper
• E. coli as an all-rounder: the thin line between commensalism and pathogenicity.

  2013cites this paper
• Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

  2013cites this paper
• An Escherichia coli Nissle 1917 Missense Mutant Colonizes the Streptomycin-Treated Mouse Intestine Better than the Wild Type but Is Not a Better Probiotic

  2013cites this paper
• Between Pathogenicity and Commensalism

  2013cites this paper
• Chapter 17 – Capsule and lipopolysaccharide

  2013cites this paper
• Molecular dynamics and NMR spectroscopy studies of E. coli lipopolysaccharide structure and dynamics.

  2013influential citation
• Tolerability and Clinical Outcome of Coseasonal Treatment with Escherichia coli Strain Nissle 1917 in Grass Pollen-Allergic Subjects

  2013cites this paper
• Probiotics: properties, examples, and specific applications.

  2013cites this paper
• The effect of probiotic Escherichia coli strain Nissle 1917 lipopolysaccharide on the 5-aminosalicylic acid transepithelial transport across Caco-2 cell monolayers.

  2013cites this paper
• Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity

  2012cites this paper
• Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells

  2012cites this paper
• Running Title : Engineered bacterium inhibits tumor growth 1 2 Title : Escherichia coli Nissle 1917 targets and restrains mouse B 16 melanoma and 4 T 1 breast 3 tumor through the expression of azurin protein

  2012cites this paper
• The wciN gene encodes an α-1,3-galactosyltransferase involved in the biosynthesis of the capsule repeating unit of Streptococcus pneumoniae serotype 6B.

  2012cites this paper
• Escherichia coli Nissle 1917 Targets and Restrains Mouse B16 Melanoma and 4T1 Breast Tumors through Expression of Azurin Protein

  2012cites this paper
• Absorption kinetics of 5-aminosalicylic acid in rat: influence of indomethacin-induced gastrointestinal lesions and Escherichia Coli Nissle 1917 medication.

  2011cites this paper